The FDA Wants to Talk Psychedelic Therapy. The Movement Has Bigger Questions.
September 17, 2026
No Comments
The FDA’s written comment period on therapeutic psychedelics closes October 5, and the notice is narrower than most people calling for comments seem to realize. The National Psychedelics Association is backing an ADA lawsuit over Oregon’s centers-only rule. Port Townsend is pushing grow-your-own, and says many of its local mushroom growers are retirees. San Francisco is training a professional class. And a Brooklyn Buddhist group is worried legalization will make the experience too easy.
